PSMB3: Proteasome 20S Subunit Beta 3

A core component of the proteasome complex involved in protein degradation and cellular homeostasis.

Gene Information Card

Symbol PSMB3
Full Name Proteasome 20S Subunit Beta 3
Gene Type Protein coding
Chromosomal Location 17q12
NCBI Gene ID 5691 ncbi.nlm.nih.gov/gene/5691
Ensembl ID ENSG00000108262
UniProt ID P49720
OMIM ID 602176
HGNC ID 9542
Aliases HC10-II, LMP10, beta1i, proteasome subunit beta type-3

Description

PSMB3 encodes a member of the proteasome B-type family, specifically the beta 3 subunit of the 20S core proteasome complex. This subunit is incorporated into the proteasome and contributes to its chymotrypsin-like, trypsin-like, and peptidyl-glutamyl peptide-hydrolyzing activities. The proteasome is essential for the degradation of ubiquitinated proteins, regulating processes such as cell cycle progression, apoptosis, and antigen presentation.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Proteasome-associated autoinflammatory syndrome (PRAAS) PSMB3 mutations may impair proteasome assembly or catalytic activity, leading to accumulation of ubiquitinated proteins and chronic inflammation. ClinVar; PMID: 25620204
Multiple myeloma Overexpression of PSMB3 has been observed in multiple myeloma, potentially contributing to proteasome hyperactivity and resistance to proteasome inhibitors. COSMIC; PMID: 23327922
Colorectal cancer Somatic mutations and altered expression of PSMB3 have been reported in colorectal cancer, possibly affecting protein homeostasis and tumor progression. COSMIC; PMID: 22810696

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 15.2 Medium
Liver 18.7 Medium
Kidney 22.1 High
Heart 14.5 Medium
Lung 16.3 Medium
Spleen 20.8 High
Cell Line Expression
Cell Line nTPM Notes
HEK 293 19.5 Embryonic kidney cells; high expression
HeLa 17.8 Cervical cancer cells; medium-high expression
K562 21.3 Leukemia cells; high expression
HepG2 18.1 Liver cancer cells; medium-high expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense <0.01% Likely loss of start codon; predicted loss of function
c.205C>T (p.Arg69Trp) Missense <0.01% May affect proteasome assembly; reported in PRAAS
c.322G>A (p.Gly108Ser) Missense <0.01% Unknown significance; found in cancer samples
Mutation functional classification

Loss of Function (LOF)

Mutations that disrupt the start codon or critical residues in the beta 3 subunit impair proteasome catalytic activity, leading to accumulation of ubiquitinated proteins.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported for PSMB3.

Dominant Negative (DN)

Some missense mutations may interfere with proteasome assembly or function in a dominant-negative manner, though evidence is limited.

Gene Ontology (GO)

• endopeptidase activity • proteasome core complex
• proteasome-mediated ubiquitin-dependent protein catabolic process • threonine-type endopeptidase activity
• cytoplasm • nucleus

Pathways

Ubiquitin mediated proteolysis (KEGG: hsa04120)
Proteasome (KEGG: hsa03050)
Antigen processing and presentation (KEGG: hsa04612)

Protein Summary

PSMB3 encodes the beta 3 subunit of the 20S proteasome core complex. This subunit is a threonine protease that contributes to the proteolytic activity of the proteasome. The protein is localized in the cytoplasm and nucleus, and is involved in the degradation of ubiquitinated proteins. PSMB3 is expressed in a wide range of tissues, with highest levels in the spleen and kidney. Mutations in PSMB3 are rare but have been associated with proteasome-associated autoinflammatory syndromes and cancer.

Related Products

Product name Cat.No. Species Gene ID
Contact Us
*
*
*
*
How did you hear about us: